In addition to the expected KRAS mutations, which occur early in pancreatic cancer’s development and are found in more than 90% of pancreatic tumors, mutations were most frequently observed in the tumor suppressor genes MLH1, TP53 and APC, as well as the oncogenes Notch1 and BRAF. Here, MLH1 is linked to pancreatic neoplasm.